KLHL2 anticorps (AA 1-200) (FITC)

N° du produit ABIN7157279

Détail du produit anti-KLHL2 anticorps (FITC)

Antigène: KLHL2 (Kelch-Like 2, Mayven (KLHL2))

Épitope: AA 1-200

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp KLHL2 est conjugé à/à la FITC

Application: Veuillez nous consulter SVP

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Kelch-like protein 20 protein (1-200AA)

Isotype: IgG

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur KLHL2

Antigène: KLHL2 (Kelch-Like 2, Mayven (KLHL2))

Autre désignation: KLHL2 (KLHL2 Produits)

Synonymes: anticorps 6030411N21Rik, anticorps ABP-KELCH, anticorps AU020744, anticorps Mav, anticorps mKIAA4249, anticorps MAV, anticorps MAYVEN, anticorps kelch-like family member 2, anticorps kelch like family member 2, anticorps kelch-like 2, Mayven, anticorps Klhl2, anticorps KLHL2

Sujet:

Background: Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex involved in interferon response and anterograde Golgi to endosome transport. The BCR(KLHL20) E3 ubiquitin ligase complex mediates the ubiquitination of DAPK1, leading to its degradation by the proteasome, thereby acting as a negative regulator of apoptosis (PubMed:20389280). The BCR(KLHL20) E3 ubiquitin ligase complex also specifically mediates \'Lys-33\'-linked ubiquitination (PubMed:24768539). Involved in anterograde Golgi to endosome transport by mediating \'Lys-33\'-linked ubiquitination of CORO7, promoting interaction between CORO7 and EPS15, thereby facilitating actin polymerization and post-Golgi trafficking (PubMed:24768539). Also acts as a regulator of endothelial migration during angiogenesis by controlling the activation of Rho GTPases. The BCR(KLHL20) E3 ubiquitin ligase complex acts as a regulator of neurite outgrowth by mediating ubiquitination and degradation of PDZ-RhoGEF/ARHGEF11 (PubMed:21670212). In case of tumor, the BCR(KLHL20) E3 ubiquitin ligase complex is involved in tumor hypoxia: following hypoxia, the BCR(KLHL20)complex mediates ubiquitination and degradation of PML, potentiating HIF-1 signaling and cancer progression (PubMed:21840486).

Aliases: Kelch like ECT2 interacting protein antibody, Kelch like protein 20 antibody, Kelch like protein X antibody, Kelch motif containing protein antibody, Kelch-like ECT2-interacting protein antibody, Kelch-like protein 20 antibody, Kelch-like protein X antibody, KHLHX antibody, KLEIP antibody, KLH20_HUMAN antibody, KLHL20 antibody, KLHLX antibody, RP3-383J4.3 antibody

UniProt: Q9Y2M5